IRIX

IRIDEX Corporation

Healthcare · $11M market cap

Verdict

We can't put a fair value on IRIX right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth-8.8% a year✗
Equity per share growth-7.6% a year✗
Sales growth1.3% a year✗
Free cash flow growth1.4% a year✗
Return on invested capital-38.0%✗

Follow IRIX

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 10, 2026: 1 open-market purchase worth $3K. Why purchases matter

Purchases

About IRIDEX Corporation

IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works